MILFORD, Mass.–(BUSINESS WIRE)–Reprieve Cardiovascular, Inc., a development stage company focused on pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, today announced it has raised a total of $42 million in series A financing. The total round was co-led by Lightstone Ventures and […]
Other News
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance DUBLIN, Feb. 20, 2024 /PRNewswire/ –…
Digital Marketing Statistics
Explore the latest digital marketing statistics, the ins and outs of Email marketing, PPC, SEO, E-commerce, influencer marketing, and more.
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,000,000 Shares
CHICAGO–(BUSINESS WIRE)–Feb. 16, 2024– GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”) at a public offering price of $82.25 per share ($80.605 per share, net of underwriting discount). GE […]
Butterfly Network, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
BURLINGTON, Mass. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will report fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer […]
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
LATHAM, N.Y., February 15, 2024–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it has completed the sale of its PICC and Midline […]
Life Line Screening, Nationwide Cardiovascular Health & Stroke Risk Screening Company, Announces Amanda Rangel as Senior Vice President of Global Business Solutions
AUSTIN, Texas–(BUSINESS WIRE)–Life Line Screening, the nation’s leading provider of mobile preventive health screenings for cardiovascular disease and stroke risk is pleased to announce the appointment of Amanda Rangel as Senior Vice President of Global Business Solutions. With her rich background in fostering corporate relationships, Amanda’s expertise will be instrumental as Life Line Screening broadens its commercial outreach. Amanda Rangel comments on her new role: “I’m thrilled to join L
30+ Internet Usage Statistics for 2024: Users, Speed, Behavior
by CodeinWP Editorial / February 12, 2024 / ideas & inspiration 30+ Internet Usage Statistics for 2024: Users, Speed, Behavior Despite being relatively new, internet technology has already revolutionized several industries and changed the way we live. With more than five billion users worldwide, internet adoption is growing, especially among […]
50+ Email Marketing Statistics for 2024: Key Insights & Trends
by CodeinWP Editorial / February 12, 2024 / ideas & inspiration 50+ Email Marketing Statistics for 2024: Key Insights & Trends What’s the ROI for email marketing? Which industries have the highest conversion rates in their email marketing campaigns? How does personalization impact the effectiveness of email marketing? This email […]
RapidAI Announces Late-Breaking Abstract Simultaneously Published in NEJM; Highlights Key Data Revealed at ISC 2024
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced the publication of the TIMELESS trial in the New England Journal of Medicine (NEJM). Other select data from research studies unveiled last week at the […]



